Evidence map›Paper›PMID 19669786›Full record

Trial reportEuropean journal of applied physiology2009

The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia.

Ryan A Harris, Steven K Nishiyama, D Walter Wray, Vince Tedjasaputra, Damian M Bailey, Russell S Richardson

Registry-linked trialAbstract readRandomized Controlled TrialValidation Study
PubMed Publisher
In one paragraph

Trial report in European journal of applied physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01398943 (Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01398943 nacompletednot on this mapstarted 2010, after this paper: background citation

Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach

TypeinterventionalSponsorAugusta UniversityRan2010 to 2015Enrolled60ConditionsPulmonary Disease, Chronic ObstructiveArmsTetrahydrobiopterin (BH4), Antioxidant Cocktail
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.American journal of physiology. Heart and circulatory physiology · 2011 · on this map
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Endothelial Dysfunction in Cystic Fibrosis: Role of Oxidative Stress.Oxidative medicine and cellular longevity · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Neurovascular coupling in humans: Physiology, methodological advances and clinical implications.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Ultrasound assessment of flow-mediated dilation.Hypertension (Dallas, Tex. : 1979) · 2010
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ryan A HarrisGeorgia Prevention Institute, Medical College of Georgia, Augusta, GA 30912, USA. ryharris@mcg.edu
Steven K Nishiyama
D Walter Wray
Vince Tedjasaputra
Damian M Bailey
Russell S Richardson
Lake City VA Medical Center · USUniversity of California, San Diego · USAugusta University · USUniversity of South Wales · GB

Funding

NEURAL CIRCULATORY CONTROL--OVARIAN HOROMONES &PREGNANCF32HL009183 · NHLBI · OHIO STATE UNIVERSITY · PI MASILAMANI, SHYAMA · 1994 to 1995
–
NHLBI NIH HHS P01 HL 09183-01A1
6 · The paper itself

Abstract

In light of the current methodological developments in flow-mediated dilation (FMD) testing and the recognition that oxidative stress may play an important role in regulating this process, the present study sought to: (1) compare flow-mediated dilation (FMD) following 5 and 10 min of forearm cuff occlusion, and (2) evaluate the role of oxidative stress on vasodilation, both distal and proximal to the cuff. Of the 14 subjects studied, 6 partook solely in a validation study of the antioxidant cocktail (AOC; vitamins C, E, and alpha-lipoic acid), while the remaining 8 subjects underwent FMD assessment in response to 5 and 10 min of forearm occlusion following ingestion of AOC or placebo. Although the efficacy of the AOC was clearly documented by elevated plasma ascorbate levels (approximately 95%) and a reduced free radical concentration (approximately 65%), no effects of acute oral antioxidants were observed. FMD was significantly augmented in response to 10 min of forearm occlusion when compared to 5 min, whether expressed as % change (10.1 +/- 2 vs. 4.5 +/- 1%, respectively) or absolute change in diameter (0.035 +/- 0.005 vs. 0.018 +/- 0.005 cm, respectively). Additionally, post-occlusion shear rate (28,640 +/- 2,799 vs. 18,629 +/- 1,724/s, AUC), FMD/shear rate (approximately 50%), and time to peak dilation (68 +/- 7 vs. 53 +/- 8 s) were greater following 10 min of occlusion. In contrast to previous studies, this investigation has identified a greater brachial artery FMD in response to 10 versus 5 min of forearm ischemia, which appears to be unexplained by oxidative stress.

Indexed as

Administration, OralAdultAntioxidantsAscorbic AcidBrachial ArteryCross-Over StudiesDouble-Blind MethodHumansHyperemiaIschemiaMalePlacebosRegional Blood FlowTime FactorsVasodilationYoung AdultAntioxidantsAscorbic AcidPlacebos

Identifiers

PMID19669786
OpenAlexW2087103784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.